Scarica l'app Stockscreener
0.9723
6.51%
-0.0677
Dopo l'orario di chiusura:
.98
0.0077
+0.79%
Xilio Therapeutics Inc Azioni (XLO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.55%
17.49
|
18.13 | 17.36 | 20.12 | 23.53 |
| Operating Income/Loss |
3.55%
-17.49
|
-18.13 | -17.36 | -20.12 | -23.53 |
| Nonoperating Income/Loss |
40.21%
0.284
|
0.475 | 0.613 | 0.761 | 0.88 |
| Income/Loss From Continuing Operations Before Tax |
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
| Income/Loss From Continuing Operations After Tax |
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
|
Net Income/Loss
|
2.56%
-17.20
|
-17.66 | -16.75 | -19.36 | -22.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
135.87K%
27.91
|
0.0205 | 27.52 | 27.47 | 27.43 |
| Basic Earnings Per Share |
3.12%
-0.62
|
-0.64 | -0.61 | -0.70 | -0.83 |
| Diluted Earnings Per Share |
3.12%
-0.62
|
-0.64 | -0.61 | -0.70 | -0.83 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):